Abstract
A number of studies have demonstrated the feasibility of amplifying the short-term repopulating progenitors in vitro and have shown the relevance of ex vivo expansion approaches in hematopoietic transplantation (1-3) and gene therapy protocols (4-5). In spite of the beneficial effects generally associated with ex vivo expansion strategies, a number of observations suggest that further studies on the biology of ex vivo expansion are required to facilitate the optimal implantation of this strategy in the clinics (6-7). In this respect, although in some instances data showing an impairment in the long-term repopulating capacity of ex vivo expanded grafts t(6), ex vivo amplifications in other cases of very primitive progenitors have been observed (9). To prevent the prompt differentiation of the hematopoietic stem cells (HSCs) during the ex vivo expansion process, new combinations of early-acting cytokines have been used to facilitate the self-renewal divisions in the HSC compartment (1,10-12).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Holyoake, T. L., Freshney, M. G., McNair, L., Parker, A. N., McKay, P. J., Steward, W. P., et al. (1996) Ex vivo expansion with stem cell factor and interleukin-11augments both shot-term recovery posttransplant and the ability to serially transplant marrow. Blood 87, 4589–4595.
Serrano, F., Varas, F., Bernad, A., and Bueren, J. A. (1994) Accelerated and longterm hematopoietic engraftment in mice transplanted with ex vivo expanded bone marrow. Bone Marrow Transplant. 14, 855–862.
Reiffers, J., Cailliot, C., Dazey, B., Attal, M., Caraux, J., and Boiron, J. M. (1999) Abrogation of post-myeloablative chemotherapy neutropenia by ex-vivo expanded autologous CD34-positive cells. Lancet 354, 1092–1093.
Bernad, A., Varas, F., Gallego, J. M., Almendral, J. M., and Bueren, J. A. (1994) Ex vivo expansion and selection of retrovirally transduced bone marrow: and efficient methodology for gene-transfer to murine lympho-haemopoietic stem cells. Br. J. Haematol. 87, 6–17.
Flasshove, M., Banerjee, D., Mineishi, S., Li, M.-X., Bertino, J. R., and Moore, M. A. S. (1995) Ex vivo expansion and selection of human CD34+peripheral blood progenitor cells after introduction of a mutated dihydrofolate reductase cDNA via retroviral gene therapy. Blood 85, 566–574.
Albella, B., Segovia, J. C., and Bueren, J. A. (1997) Does the granulocytemacrophage colony-forming unit content in ex vivo-expanded grafts predict the recovery of the recipient leukocytes? Blood 90, 464–470.
Guenechea, G., Segovia, J. C., Albella, B., Lamana, M., Ramirez, M., Regidor, C., et al. (1999) Delayed engraftment of nonobese diabetic/severe combined immunodeficient mice transplanted with ex vivo-expanded human CD34(+) cord blood cells. Blood 93, 1097–1105.
Peters, S. O., Kittler, L. W., Ramshaw, H. S., and Quesenberry, P. J. (1996) Ex vivo expansion of murine marrow cells with interleukin-3 (IL-3), IL-6, IL-11, and stem cell factor leads to impaired engraftment in irradiated hosts. Blood 87, 30–37.
Piacibello, W., Sanavio, F., Garetto, L., Severino, A., Bergandi, D., Ferrario, J., et al. (1997) Extensive amplification and self-renewal of human primitive hematopoietic stem cells from cord blood. Blood 89, 2644–2653.
Yonemura, Y., Ku, H., Lyman, S. D., and Ogawa, M. (1996) In vitro expansion of hematopoietic progenitors and maintenance of stem cells: Comparison between FLT3/FLK-2 ligand and KIT ligand. Blood 89, 1915–1921.
Bhatia, M., Bonnet, D., Kapp, U., Wang, J. C., Murdoch, B., and Dick, J. E. (1997) Quantitative analysis reveals expansion of human hematopoietic repopulating cells after short-term ex vivo culture. J. Exp. Med. 186, 619–624.
Conneally, E., Cashman, J., Petzer, A., and Eaves, C. (1997) Expansion in vitro of transplantable human cord blood stem cells demonstrated using a quantitative assay of their lympho-myeloid repopulating activity in nonobese diabetic-scid/scid mice. Proc. Natl. Acad. Sci. USA 94, 9836–9841.
Testa, N. and Molineux, G. (1993) Haemopoiesis. A practical approach, in The Practical Approach, vol. 111 (Rickwood, D., ed.), Oxford University Press, New York, p. 293.
Ploemacher, R. E., van der Sluijs, J. P., Voerman, J. S., and Brons, N. H. (1989) An in vitro limiting-dilution assay of long-term repopulating hematopoietic stem cells in the mouse. Blood 74, 2755–2763.
Lemieux, M. E., Rebel, V. I., Lansdorp, P. M., and Eaves, C. J. (1995) Characterization and purification of a primitive hematopoietic cell type in adult mouse marrow capable of lymphomyeloid differentiation in long-term marrow "e;switch"e; cultures. Blood 86, 1339–1347.
Larochelle, A., Vormoor, J., Hanenberg, H., Wang, J. C., Bhatia, M., Lapidot, T., et al. (1996) Identification of primitive human hematopoietic cells capable of repopulating NOD/SCID mouse bone marrow: implications for gene therapy. Nat. Med. 2, 1329–1337.
Harrison, D. E., Jordan, C. T., Zhong, R. K., and Astle, C. M. (1993) Primitive hemopoietic stem direct cells: assay of most productive populations by competitive repopulation with simple binomial, correlation and covariance calculations. Exp. Hematol. 21, 206–219.
Albella, B., Segovia, J. C., Guenechea, G., Pragnell, I. B., and Bueren, J. A. (1999) Preserved long-term repopulation and differentiation properties of hematopoietic grafts subjected to ex vivo expansion with stem cell factor and interleukin 11. Transplantation 67, 1348–1357.
Keyes, K. A., Segovia, J. C., Bueren, J. A., Parchment, R. E., and Albella, B. (2001) Latent hematopoietic stem cell toxicity associated with protracted drug administration. Exp. Hematol. 29, 286–294.
Barquinero, J., Segovia, J. C., Ramirez, M., Limon, A., Guenechea, G., Puig, T., et al. (2000) Efficient transduction of human hematopoietic repopulating cells generating stable engraftment of transgene-expressing cells in NOD/SCID mice. Blood 95, 3085–3093.
Rubinstein, P., Dobrila, P., Rosenfield, R. E., Adamson, J. W., Migliaccio, G., Migliaccio, A. R., Taylor, P. E., and Stevens, C. E. (1995) Processing and cryopreservation of placental/umbilical cord blood for unrelated bone marrow reconstitution. Proc. Natl. Acad. Sci. USA 92, 10119–10122.
Varas, F., Bernad, A., and Bueren, J. A. (1996) Granulocyte colony-stimulating factor mobilizes into peripheral blood the complete clonal repertoire of hematopoietic precursors residing in the bone marrow of mice. Blood 88, 2495–2501.
Peled, A., Petit, I., Kollet, O., Magid, M., Ponomaryov, T., Byk, T., et al. (1999) Dependence of human stem cell engraftment and repopulation of NOD/SCID mice on CXCR4. Science 283, 845–848.
Guenechea, G., Gan, O. I., Dorrell, C., and Dick, J. E. (2001) Distinct classes of human stem cells that differ in proliferative and self-renewal potential. Nat. Immunol. 2, 75–82.
Kamel-Reid, S. and Dick, J. E. (1988). Engraftment of immune-deficient mice with human hematopoietic stem cells. Science 242, 1706–1709.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2003 Humana Press Inc.
About this protocol
Cite this protocol
Albella, B., Carlos Segovia, J., Guenechea, G., Antonio Bueren, J. (2003). 27 Ex Vivo Expansion of Hematopoietic Stem Cells. In: Körholz, D., Kiess, W. (eds) Cytokines and Colony Stimulating Factors. Methods in Molecular Biology, vol 215. Humana, Totowa, NJ. https://doi.org/10.1385/1-59259-345-3:363
Download citation
DOI: https://doi.org/10.1385/1-59259-345-3:363
Publisher Name: Humana, Totowa, NJ
Print ISBN: 978-1-58829-035-9
Online ISBN: 978-1-59259-345-3
eBook Packages: Springer Protocols